Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
In a new study, participants who exercised 150 minutes per week—whether on one or two days, or more consistently—saw a host ...
Now, researchers have identified ... Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of ...
Dorothy Sorlie, at one point, was afraid her life was coming to an abrupt end. “My husband hadn’t given up, but I did,” said Sorlie. “I thought, ‘Well, this is the way life is.’” From being fairly ...
New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in ...
( MENAFN - IANS) New Delhi, Feb 4 (IANS) The global Parkinson's disease (PD) market is expected to grow to $7.9 billion by 2033 from $3.4 billion in 2023, according to a report.
2d
FOX 13 Tampa Bay on MSNStudy suggests high levels of microplastics in the human brain from everyday itemsTAMPA, Fla. - Researchers are finding higher levels of microplastics in human brains. A new study done by researchers at the ...
5d
The St. Lucie News-Tribune on MSNGrant helps local Alzheimer & Parkinson Association buy transmitters, tracking devicesA grant from the Alzheimer’s Foundation of America will be used to purchase equipment to serve families affected by ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results